ÃÀʨ¹ó±ö»á

ÊÖ³Öʽ¹âÆ×ÒÇÊÖ³ÖʽºÏ½ðÆÊÎöÒǺϽðÆÊÎöÒÇ
¹ÉƱ´úÂ룺300165 ÆóÒµÓÊÏä Ͷ×ÊÕß¹ØÏµ
ÃÀʨ¹ó±ö»á(Öйú)ÓÐÏÞ¹«Ë¾-Official website

ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ GC-MS

ÄúÄ¿½ñËùÔÚÒ³£ºÊ×Ò³ > ½â¾ö¼Æ»® > ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ GC-MS

ÆøÏàÉ«Æ×-ÖÊÆ×ÁªÓ÷¨£¨GC-MS£©²âÊÔÒ½ÁÆÆ÷е²úÆ·ÖеÄTOTM

Ðû²¼ÈÕÆÚ£º2020/9/24 10:36:52  µã»÷´ÎÊý£º52350

Æ«±½ÈýËáÈýÐÁõ¥(TOTM), ÒòÆäÁ¼ºÃµÄËÜ»¯ÐÔ¡¢ÄÍÇ¨ÒÆÐÔ¡¢Ä͸ßÎÂÒÔ¼°µÍ¶¾ÐÔ £¬±»ÈÏΪÊÇ¿ÉÌæ´úÁÚ±½¶þ¼×Ëá¶þ(2-ÒÒ»ù¼º»ù)õ¥(DEHP)µÄÒ»ÖÖÓÅÁ¼ÔöËܼÁ¡£¾¡¹ÜĿǰûÓгä·ÖÖ¤¾ÝÏÔʾҽÁÆÆ÷еÖÐTOTM¶ÔÈËÌåÓÐÏÔÖøµÄÓ°Ïì £¬¿ÉÊÇ £¬¶¯ÎïʵÑé±êÃ÷TOTMÔÚ´úлµÄÀú³ÌÖлá»ýÀÛÔÚ×éÖ¯Àï¡£¿¼²ìTOTMµÄÈܳöÁ¿µÄÓ°ÏìÒòËØÒÔ¼°ÈËÌå¿É½ÓÊܵÄÄÍÊÜÏÞÁ¿ £¬ÌرðÊÇһЩÐÂÉú¶ù¡¢ÓÐÉí»ò²¸È鸾ŮµÈ¸ßÃô¸ÐȺÌåÊÇÊ®·ÖÐëÒªµÄ¡£½ÓÄÉGC-MS 6800ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ £¬¶ÔÒ½ÁÆÆ÷еPVCÖÐTOTM½øÐÐ¼à¿Ø £¬»ñµÃÁ˱ȽÏÂúÒâµÄ²âÊÔЧ¹û¡£


1.ÒÇÆ÷¼ò½é

GC-MS 6800ÊÇÃÀʨ¹ó±ö»áÒÇÆ÷¾«ÐÄ´òÔìµÄÒ»¿î¸ßÐÔ¼Û±ÈÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ £¬¾ßÓÐÍêÈ«µÄ×ÔÖ÷֪ʶ²úȨ £¬ÓµÓжàÏîרÀû¼¼Êõ £¬¿É¹ã·ºÓ¦ÓÃÓڸ߷Ö×ÓÖÊÁÏ¡¢Çé¿ö±£»¤¡¢µç×ÓµçÆ÷¡¢Ò½Ò©¡¢Ê¯ÓÍ»¯¹¤¡¢Ê³Æ·Äþ¾²¡¢·Ä֯Ƥ¸ïµÈ¶àÐÐÒµÖÐÓк¦ÎïÖʵļì²â¡£


ÃÀʨ¹ó±ö»á(Öйú)ÓÐÏÞ¹«Ë¾-Official website

ͼ1.GC-MS 6800ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇÍâ¹Ûͼ


2.ʵÑ鲿·Ö

2.1 ²âÊÔÔ­Àí

ÑùÆ·¾­¼ôËéºó׼ȷ³ÆÈ¡ £¬¾­ÒÒËáÒÒõ¥ÝÍÈ¡¹ýÂ˺ó £¬ÓÃGCMSÆÊÎö¡£ÒÀ¾ÝÄ¿±ê»¯ºÏÎïµÄ±£´æÊ±¼äºÍ±ê×¼ÖÊÆ×ͼ»òÌØÕ÷Àë×Ó¶¨ÐÔ £¬ÓÃÍâ±ê·¨¶¨Á¿¡£

2.2Ö÷ÒªÒÇÆ÷É豸¡¢ºÄ²ÄºÍÊÔ¼Á

GC-MS 6800 ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ £¬ÅäÓÐEI£¨ÃÀʨ¹ó±ö»á£©£»

ÆÊÎöÌìÆ½£º¾«¶ÈÊ®Íò·ÖÖ®Ò»£¨BT 125D £¬Èü¶àÀû˹¿ÆÑ§ÒÇÆ÷£¨±±¾©£©ÓÐÏÞ¹«Ë¾£©£»

Æ«±½ÈýËáÈýÐÁõ¥£¨TOTM£©±ê׼Ʒ£º¦Ñ=1000mg/L £¨¹ú¼Ò±ê×¼ÎïÖÊÍø£©£»

ÒÒËáÒÒõ¥£ºHPLC¼¶£¨Ä¬¿Ë£©¡£

Õý¼ºÍ飺HPLC¼¶£¨Ä¬¿Ë£©¡£

2.2 ÒÇÆ÷²âÊÔÌõ¼þ

É«Æ×Öù£ºDB-5MS £¬15m¡Á0.25mm¡Á0.1¦Ìm£»

ÖùÏä³ÌÐòÉýÎÂÌõ¼þ£º³õʼζÈ100¡æ £¬20¡æ/minÉýÖÁ280¡æ¼á³Ö6min£»

½øÑù·½·¨£º²»·ÖÁ÷½øÑù £¬²»·ÖÁ÷ʱ¼ä1min £¬·ÖÁ÷±È20:1£»

½øÑùÁ¿£º1.0¦ÌL£»

½øÑù¿Úζȣº280¡æ£»

ÆøÖʽӿÚζȣº280¡æ£»

Àë×ÓԴζȣº280¡æ£»

ÔØÆø£ºº¤Æø £¬´¿¶È¡Ý99.999% £¬Á÷ËÙ1.0mL/min£»

µçÀë·½·¨£ºEI£»

µçÀëÄÜÁ¿£º70eV£»

ÈܼÁÇгýʱ¼ä£º4min£»

²â¶¨·½·¨£ºTIC£¨FULL SCAN£©¶¨ÐÔ£¨É¨Ãè¹æÄ££º45-450amu£© £¬SIMģʽ¶¨Á¿¡£


3.²âÊÔ½á¹û

3.1 TOTM±ê×¼ÎïÖÊ×é·Ö¶¨ÐÔ½á¹û

ÃÀʨ¹ó±ö»á(Öйú)ÓÐÏÞ¹«Ë¾-Official website

1.TOTM

ͼ2. TOTM±ê×¼ÎïÖÊ×ÜÀë×ÓÁ÷É«Æ×ͼ

ÃÀʨ¹ó±ö»á(Öйú)ÓÐÏÞ¹«Ë¾-Official website

ͼ3.TOTMÖÊÆ×ͼ


±í1.Ä¿±êÎï»ù±¾²âÊÔÐÅÏ¢

»¯ºÏÎï

Ó¢ÎÄÃû³Æ

CASºÅ

ÌØÕ÷Àë×Ó

Æ«±½ÈýËáÈýÐÁõ¥

TOTM

3319-31-1

350* 306 323 193


3.2 ÑùÆ·²âÊÔ

ÃÀʨ¹ó±ö»á(Öйú)ÓÐÏÞ¹«Ë¾-Official website

ͼ4.ʵ¼ÊÑùÆ·²âÊÔͼ

4.×ܽá

±¾ÊµÑé½ÓÄÉÆøÏàÉ«Æ×ÖÊÆ×ÁªÓ÷¨£¨GC-MS£© £¬ÔÚSIMɨÃèģʽ϶ÔÒ½ÁÆÆ÷еÖÐTOTM½øÐж¨ÐÔ¶¨Á¿²âÊÔ £¬ÒªÁìÎȶ¨¿É¿¿ £¬ÏßÐÔ¹æÄ£ºÃ £¬ÁéÃô¶È¸ß £¬ÊÜÔÓÖÊ·å×ÌÈÅС £¬ÍêÈ«ÇкϲâÊÔÒªÇó¡£

5£®²Î¿¼ÎÄÏ×

[1] HG/T 3874-2018 ¹¤ÒµÆ«±½ÈýËáÈý£¨2-ÒÒ»ù¼º»ù£©õ¥£¨TOTM£©

[2] GB/T 16886.17-2005 Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ17²¿·Ö£º¿ÉÁ¤ÂËÎïÔÊÐíÏÞÁ¿µÄ½¨Á¢

[3] IS0 10993-17:2002 Biological evaluation of medical devices ¨C Part 17: Establishment of allowable limits for leachable substances 

Ïà¹Ø²úÆ·

ÁªÏµÃÀʨ¹ó±ö»á

Á˽â¸ü¶àÏêϸÐÅÏ¢ £¬ÇëÖµç
400-7102-888
·ÇÊÂÇéʱ¼äЧÀÍÈÈÏß
139 1323 1381
¸øÎÒÃÇÁôÑÔ
ÔÚÏßÁôÑÔ
΢ÐÅÊÛºóЧÀͶþάÂë

ÍøÕ¾µØÍ¼